Table 2 Morbidity measures by age, gender and Socioeconomic status
n | Females (%) | Age (mean, ±SD, CI95%) | Age group (%) | Socioeconomic status (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
< 65 | 65–74 | 75–84 | > 84 | Very High | High | Mode-rate | Poor | Very poor | ||||
Charlson index | ||||||||||||
0 | 3,773,271 | 49.3 | 40.85, ± 13.8, 40.83–40.86 | 94.1 | 4.3 | 1.3 | 0.4 | 14.6 | 28.2 | 17.2 | 26.7 | 13.4 |
1 | 1,068,689 | 55.7 | 55.89, ± 15.8, 55.86–55.92 | 69.3 | 18.1 | 9.4 | 3.3 | 9.4 | 19.9 | 40.2 | 20.7 | 9.8 |
2 | 536,386 | 56.1 | 63.51, ± 14.9, 63.47–63.55 | 49.6 | 26.3 | 17.3 | 6.8 | 9.4 | 19.9 | 39.6 | 21.0 | 10.1 |
3 | 302,559 | 55.3 | 69.15, ± 13.7, 69.10–69.20 | 33.7 | 28.6 | 25.4 | 12.3 | 9.7 | 20.3 | 39.2 | 20.5 | 10.3 |
4 | 175,582 | 52.7 | 73.05, ± 12.3, 72.99;73.10 | 22.9 | 27.8 | 31.7 | 17.7 | 9.3 | 20.2 | 39.1 | 20.7 | 10.7 |
5 | 99,865 | 50.8 | 75.52, ± 11.5, 75.45–75.59 | 16.5 | 25.1 | 35.8 | 22.6 | 8.8 | 20.3 | 38.9 | 21.0 | 11.0 |
6 | 68,717 | 44.0 | 71.21, ± 16.8, 71.08–71.34 | 27.7 | 19.0 | 31.1 | 22.2 | 9.2 | 20.9 | 37.5 | 20.6 | 11.7 |
7 | 37,128 | 42.9 | 73.75, ± 14.6, 73.60–73.90 | 22.7 | 19.3 | 33.6 | 24.4 | 8.8 | 20.5 | 37.8 | 20.6 | 12.3 |
> 7 | 40,398 | 40.2 | 74.38, ± 13.5, 74.25–74.51 | 21.3 | 19.9 | 34.9 | 23.9 | 8.2 | 20.5 | 38.3 | 20.8 | 12.2 |
CRG status (a) | ||||||||||||
Healthy/Non-Users | 3,610,832 | 48.6 | 40.27, ± 13.5, 40.25–40.28 | 95.0 | 3.5 | 1.1 | 0.4 | 10.9 | 20.8 | 38.9 | 19.5 | 9.8 |
History of significant acute disease | 111,709 | 55.4 | 47.96, ± 15.9, 47.87;48.05 | 83.6 | 10.3 | 4.3 | 1.8 | 8.3 | 19.1 | 40.8 | 21.1 | 10.7 |
Single minor chronic disease | 423,418 | 65.8 | 52.35, ± 14.6, 52.31–52.39 | 79.2 | 14.1 | 5.0 | 1.6 | 9.3 | 20.2 | 40.6 | 20.4 | 9.5 |
Minor chronic disease in multiple systems | 119,540 | 79.5 | 61.07, ± 12.8, 61.00–61.15 | 59.6 | 25.9 | 11.4 | 3.0 | 9.8 | 20.4 | 40.3 | 20.1 | 9.3 |
Single dominant or moderate chronic disease | 1,026,770 | 50.8 | 61.25, ± 16.4, 61.22–61.29 | 54.8 | 22.7 | 15.4 | 7.0 | 9.2 | 20.1 | 39.7 | 20.8 | 10.1 |
Significant chronic disease in multiple systems | 758,547 | 52.7 | 70.11, ± 13.5, 70.08–70.14 | 31.0 | 28.1 | 27.4 | 13.5 | 8.8 | 19.6 | 39.5 | 21.3 | 10.8 |
Dominant chronic disease in > 2 systems | 36,668 | 55.8 | 74.92, ± 11.9, 74.80;75.04 | 18.7 | 22.5 | 37.4 | 21.4 | 8.7 | 19.1 | 38.8 | 21.8 | 11.6 |
Dominant and metastatic malignancies | 3455 | 23.6 | 70.92, ± 14.0, 70.45–71.39 | 29.2 | 26.0 | 28.1 | 16.7 | 9.8 | 19.9 | 41.0 | 19.7 | 9.6 |
Catastrophic condition | 11,656 | 27.7 | 47.97, ± 11.0, 47.77–48.17 | 92.5 | 5.6 | 1.6 | 0.2 | 11.9 | 22.2 | 32.6 | 19.6 | 13.7 |
GMA morbidity level (a) | ||||||||||||
Healthy | 1,007,734 | 41.0 | 40.68, ± 13.4, 40.66–40.71 | 95.1 | 3.4 | 1.1 | 0.5 | 16.2 | 22.9 | 36.0 | 16.9 | 8.0 |
Acute pathologies | 531,707 | 43.2 | 36.93, ± 12.1, 36.90–36.97 | 97.5 | 1.8 | 0.5 | 0.2 | 10.3 | 20.1 | 40.4 | 19.8 | 9.4 |
Pregnancy and childbirth | 79,064 | 100.0 | 32.60, ± 5.8, 32.56–32.64 | 100.0 | 0.0 | 0.0 | 0.0 | 6.6 | 18.0 | 40.9 | 22.1 | 12.3 |
Chronic pathologies in 1 system | 1,231,874 | 47.1 | 40.87, ± 13.6, 40.84–40.89 | 94.4 | 3.9 | 1.2 | 0.4 | 9.7 | 20.2 | 40.1 | 20.2 | 9.7 |
Chronic pathologies in 2 or 3 systems | 1,707,743 | 54.1 | 49.54, ± 16.5, 49.51–49.56 | 80.5 | 12.1 | 5.4 | 2.0 | 8.6 | 19.8 | 40.3 | 21.0 | 10.4 |
Chronic pathologies in > 3 systems | 1,273,579 | 60.2 | 65.40, ± 16.1, 65.37–65.42 | 43.7 | 24.3 | 21.3 | 10.7 | 8.2 | 19.9 | 39.4 | 21.1 | 11.3 |
Active neoplasm | 270,894 | 50.5 | 67.94, ± 14.5, 67.89–68.00 | 36.1 | 27.8 | 25.1 | 11.0 | 10.2 | 20.9 | 38.3 | 20.4 | 10.1 |